We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Canadian drugmaker Valeant Pharmaceuticals is buying Egypt’s largest drugmaker, Amoun Pharmaceutical, for about $800 million — giving the firm a platform for further expansion in the region.